ANI Aims For CGT Top Spot With Two New Launches
Firm Says Latest Competitive Generic Therapy Approvals Make It Joint Leader In US
ANI Pharmaceuticals has heralded the approval and launch of two new US competitive generic therapies as giving it a joint leadership position in the CGT space.